Refine by
Human Diagnostic Articles & Analysis
21 news found
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced release of its new line of Human Hybrid IgM Control Monoclonal Antibodies for research applications, covering a range of diseases such as CMV, HSV, MeV, MuV, RuV, and VZV.Characteristic disease state sera are serum samples derived from individuals with ...
Several disease models of Zika virus infection have been established in mice and non-human primates (NHPs) and used for diagnostic, therapeutic and preclinical evaluation of Zika virus vaccines. ...
With expertise in antibody generation and immunoassay development, Creative Diagnostics can generate various diagnostic antibodies covering a wide range of diseases, including infectious diseases, cardiovascular diseases, cancer and bone diseases, especially osteoporosis. ...
Microbiome research has rapidly gained momentum in recent years as scientists have come to appreciate the vital role that microbial communities play in maintaining human health. However, analyzing the vast amounts of data generated by high-throughput sequencing of microbiome samples can be a daunting task. ...
Lifespin will now be able to scan and create the corresponding digitized, quantitative metabolic profiles involving as many as 300,000 human samples per year. “These additional resources will support our recently launched commercial services which, for the first time, will provide the pharmaceutical and biobanking industries with access to our proprietary metabolic ...
This antibody is used for research only, not for human, therapeutic or diagnostic applications. The high specificity and sensitivity of antibodies are unique advantages in biomedical research applications. ...
xCures, Inc. is proud to announce their collaboration with mProbe Inc., a premier CLIA-certified targeted proteomics company. mProbe utilizes a proprietary technology platform integrating artificial intelligence and multi-omic diagnostics to transform the diagnosis, prevention, and treatment of complex diseases such as cancer. ...
ByxCures
Founded in 2009 and headquartered in Boulder, Colorado, LightDeck has developed a scalable and innovative platform for rapid and accurate point of care diagnostics. LightDeck’s 80-member team includes industry veterans, engineers, and scientists, with deep technical expertise in assay development, manufacturing, and software development, who have collaborated with ...
On World Alzheimer’s Day, Missouri leaders and economic development officials praise C2N Diagnostics for deciding to continue to grow its St. Louis-based company which is receiving international recognition for developing and accelerating novel diagnostics and therapies for Alzheimer’s disease. ...
These features help make the test more accessible than other diagnostic methods that physicians use to evaluate issues with memory and thinking. About C2N Diagnostics, LLC C2N’s Diagnostics’ vision is to bring Clarity Through Innovation™. It focuses its therapeutic discovery efforts around mechanism-based approaches to prevent ...
The OPTI Rapid Lysis Buffer has shown a diagnostic sensitivity and specificity of 100 % when compared to magnetic bead extraction. The PCR testing workflow for SARS-CoV-2 from OPTI Medical comes with the following benefits: High sensitivity and specificity as proven by internal and external validations Extraction-free sample handling with savings in instruments, reagents, ...
These features make the test more accessible than other diagnostic methods that physicians use to evaluate issues with memory and thinking. ...
C2N Diagnostics, which offers the PrecivityAD™ blood test that can help detect if certain markers for Alzheimer’s disease are in the brain, now has its analytical validation results available for review. ...
The U.S. Department of Health and Human Services’ Centers for Medicare & Medicaid Services manages CLIA certification. ...
These features make the test more accessible than other diagnostic methods that physicians use to evaluate issues with memory and thinking. ...
A breakthrough in Alzheimer’s disease has arrived with the introduction of C2N Diagnostics’ PrecivityAD™ blood test into the clinic. Researchers at C2N Diagnostics have found the PrecivityAD™ test predicts Alzheimer’s brain pathology in people with memory and thinking issues. ...
(NYSE: QGEN; Frankfurt Prime Standard: QIA), a leading global provider of Sample to Insight molecular diagnostics and sample preparation technologies, today announced that they have entered into an amendment to their acquisition agreement under which Thermo Fisher has commenced a tender offer to acquire all of the ordinary shares of QIAGEN. ...
StemBioSys introduced a new culture system designed to help investigators grow human chondrocytes in vitro faster while retaining a natural phenotype. The kit is comprised of CELLvo™ Matrix, a cell-derived extracellular matrix that mimics the chondrocytes’ natural microenvironment, and CELLvo™ Human Articular Chondrocytes, a collection of ...
The test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the U.S. ...
The OPTI SARS-CoV-2 RT-PCR test kit detects human RNase P as an internal sample control and endogenous nucleic acid to control for sample addition, extraction and amplification. ...